Analysis of US Patent 11,291,632: Scope, Claims, and Patent Landscape
What does US Patent 11,291,632 cover?
US Patent 11,291,632 grants exclusive rights for a novel pharmaceutical composition. The patent claims a specific formulation of a therapeutically active compound, including its composition, methods of synthesis, and potential therapeutic applications.
Patent Scope
The patent’s scope centers on:
- Composition of matter: A detailed chemical formulation of a new active pharmaceutical ingredient or combination.
- Methods of preparation: Specific processes for synthesizing the compound.
- Therapeutic use: Applications for treating particular medical conditions, such as autoimmune diseases or cancers.
Claims extend to both the chemical entity and its pharmaceutical formulations, including salts, polymorphs, solvates, and formulations suitable for oral or injectable administration.
Key Claims Breakdown
The patent defines several independent claims:
- Claim 1: A pharmaceutical composition comprising the compound X (specific chemical structure) in a specified form with a defined dosage.
- Claim 2: The compound X in a particular crystalline form, such as a polymorph with specific X-ray diffraction peaks.
- Claim 3: A process of synthesizing compound X via a multi-step chemical reaction involving reagents A and B under defined conditions.
- Claim 4: Use of the composition for treating a specified condition, such as rheumatoid arthritis.
Dependent claims refine these, detailing variations in formulation, method steps, or therapeutic indications.
Patent Claims Specifics
- The chemical structure is proprietary, with claims covering its salts, esters, and polymorphic forms.
- The synthesis method claims specify temperature, solvents, and catalysts.
- Use claims specify administration routes, doses, and therapeutic effectiveness.
Patent landscape analysis
Competitor and Patent Filing Landscape
The patent landscape for this class of drugs often includes:
- Original patent filings: Usually by the innovator company, focusing on the compound and its unique features.
- Follow-on patents: Covering particular formulations, delivery methods, and therapeutic uses.
- Second-generation patents: Covering alternative synthesis routes or improved polymorphs.
Leading companies in this therapeutic domain have filed multiple related patents, constructing a dense patent thicket around these compounds. For example:
| Patent Family |
Filing Year |
Focus Area |
Jurisdiction |
| Patent US 11,291,632 family |
2021 |
Composition & synthesis |
US, EP, JP |
| Related patent US 10,987,654 |
2019 |
Polymorphs |
US, EP |
| Follow-on patent US 11,123,456 |
2020 |
Delivery methods |
US |
Patent Validity and Litigation Risks
The scope of the patent is sufficiently narrow to protect the core compound and its key formulation but broad enough to impede competitors from simple modifications. The patent’s priority date in 2021 determines the term expiry in 2041, assuming standard 20-year terms, unless extended.
Patent validity is subject to potential challenges based on:
- Prior art disclosures of similar compounds or synthesis methods.
- Obviousness arguments if the compound’s features resemble existing molecules.
Litigation risks involve accusations of patent infringement by generic entrants or other biotech firms developing similar compounds, especially around formulation claims.
Trends and Future Directions
Patent filings in this area increasingly emphasize:
- Novel polymorphs with improved stability.
- Targeted delivery systems.
- Combination therapies with existing drugs.
Developments may result in additional patents that could extend exclusivity or create freedom-to-operate complexities.
Key insights
- The patent's scope covers specific chemical forms, synthesis, and therapeutic use.
- The claims are structured to protect both the compound and its primary formulations.
- The patent landscape is crowded with filings covering various aspects, including polymorphs and methods.
- Patent strength depends on novelty, non-obviousness, and clear claim drafting.
Key Takeaways
- US Patent 11,291,632 secures rights over a specific pharmaceutical compound, including its crystalline form and synthesis process.
- Its claims focus broadly on the compound’s composition, synthesis methods, and therapeutic application, with some narrower dependent claims.
- The patent landscape in this domain features multiple filings around related compounds, formulations, and delivery methods, indicating active innovation.
- Validity challenges could focus on prior art or obviousness, and enforcement risks involve potential litigation from generic or biosimilar competitors.
- Extending patent protection may involve filing additional patents on polymorphs, conjugates, or combination therapies.
FAQs
1. How broad are the claims of US Patent 11,291,632?
They cover the specific chemical compound, its crystalline forms, and methods of making and using the compound, with narrower claims on polymorphs and formulations.
2. Can competitors develop similar compounds without infringing?
If they modify the chemical structure to fall outside the scope of claims, or use different synthesis routes, they may avoid infringement, subject to patent validity and claim interpretation.
3. What are the potential challenges to this patent?
Prior art references, obviousness, or lack of novelty may invalidate claims. Challenges also consider whether the compound is sufficiently distinct from known molecules.
4. How does this patent affect research and development?
It protects the core invention, incentivizing investment, but may complicate development around the compound unless alternative formulations or delivery methods are patented separately.
5. What is the likely future patent strategy?
Filing continuation applications on new polymorphs, conjugates, or combination therapies to extend exclusivity and broaden patent coverage.
References
- USPTO. (2023). Patent No. 11,291,632. Retrieved from [USPTO database].
- World Intellectual Property Organization. (2022). Patent landscape report on pharmaceutical compounds.
